Recently announced provincial reimbursement drug lists (PRDLs) provide possible new opportunities for US pharmaceutical companies seeking to expand market reach for their drugs in China.
China Market Intelligence
Copyright-related intellectual property (IP) disputes in China have increased as a result of the growth of online streaming services and domestic media studios.
New policies simplifying the visa process to attract foreign talen
Newly released ministerial plans set national intellectual property (IP) priorities to further the central government’s top-down drive to reform China’s IP laws.
A recently released draft regulation requires a 30-day public comment period for all rules and measures issued by agencies under the authority of the State Council, as well as provincial and local governments.
Although structural issues remain, China’s legal system has become more transparent under President Xi Jinping, according to panelists at a recent US-China Working Group event hosted by the US-China Business Council (USCBC) and the National Bureau of Asian Research.
China expanded data localization requirements and instituted new rules for outbound
Integrating China’s national and local intellectual property (IP) agencies through reforms
Wholly foreign-owned enterprise (WFOE) wealth management firms can now directly invest in the Chinese market as a result of new licensing reforms.